Recent Quarter Total Invested
$3.26 B
Recent Quarter Institutional Ownership Percentage
82.75%
Total Invested of Last Quarter
$951.99 M
Ownership Percentage of Last Quarter
81.25%
Verona Pharma plc Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 6.32 M | $181.71 M | 159.52% | 7.75% |
NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 5.58 M | $160.67 M | 0.00% | 6.85% |
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 5.01 M | $144.13 M | -34.37% | 6.15% |
MAVERICK CAPITAL LTD | 11/14/2024 | 4.22 M | $121.29 M | 36.32% | 5.17% |
VIVO CAPITAL, LLC | 11/13/2024 | 3.55 M | $102.13 M | 0.00% | 4.36% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 3.38 M | $97.36 M | 2.10% | 4.15% |
DEEP TRACK CAPITAL, LP | 11/14/2024 | 3.18 M | $91.49 M | -20.50% | 3.90% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 2.43 M | $69.79 M | 359.63% | 2.98% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 1.88 M | $54.05 M | 19.55% | 2.31% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 1.84 M | $52.80 M | -3.17% | 2.25% |
JENNISON ASSOCIATES LLC | 11/08/2024 | 1.74 M | $50.09 M | 54.33% | 2.14% |
CALIGAN PARTNERS LP | 11/14/2024 | 1.44 M | $41.34 M | -22.07% | 1.76% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.43 M | $41.25 M | 34.96% | 1.76% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.34 M | $38.41 M | 40.64% | 1.64% |
BELLEVUE GROUP AG | 11/14/2024 | 1.22 M | $35.10 M | 7.57% | 1.50% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.18 M | $33.89 M | 1,048.00% | 1.45% |
AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 1.12 M | $32.09 M | 0.00% | 1.37% |
LOOMIS SAYLES & CO L P | 11/13/2024 | 1.11 M | $31.97 M | 100.00% | 1.36% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.04 M | $30.02 M | -4.51% | 1.28% |
RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 985,076 | $28.34 M | 4.84% | 1.21% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 876,604 | $25.22 M | -0.16% | 1.08% |
CANDRIAM S.C.A. | 11/13/2024 | 772,997 | $22.24 M | 0.00% | 0.95% |
DUQUESNE FAMILY OFFICE LLC | 11/14/2024 | 686,045 | $19.74 M | 100.00% | 0.84% |
AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 650,000 | $18.70 M | -7.14% | 0.80% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 626,452 | $18.02 M | 5.22% | 0.77% |
TRI LOCUM PARTNERS LP | 11/14/2024 | 593,980 | $17.09 M | 100.00% | 0.73% |
MORGAN STANLEY | 11/14/2024 | 590,909 | $17.00 M | -31.61% | 0.73% |
FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 572,928 | $16.48 M | 100.00% | 0.70% |
FRANKLIN RESOURCES INC | 11/12/2024 | 559,728 | $19.18 M | 100.00% | 0.69% |
WOODLINE PARTNERS LP | 11/14/2024 | 507,945 | $14.61 M | 1.35% | 0.62% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 504,049 | $14.50 M | -17.51% | 0.62% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 434,738 | $12.51 M | 100.00% | 0.53% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 409,070 | $11.77 M | -52.18% | 0.50% |
CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 405,741 | $11.67 M | -0.02% | 0.50% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 378,004 | $10.88 M | -1.61% | 0.46% |
KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 358,447 | $10.31 M | 6.20% | 0.44% |
SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 348,866 | $10.04 M | 14.52% | 0.43% |
AXA S.A. | 11/14/2024 | 278,025 | $8.00 M | 100.00% | 0.34% |
ROSALIND ADVISORS, INC. | 10/30/2024 | 275,000 | $7.91 M | 10.00% | 0.34% |
CITADEL ADVISORS LLC | 11/14/2024 | 263,400 | $7.58 M | 65.76% | 0.32% |
MOODY ALDRICH PARTNERS LLC | 10/22/2024 | 252,752 | $7.27 M | -14.59% | 0.31% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 250,000 | $7.19 M | 100.00% | 0.31% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 239,300 | $6.88 M | 888.84% | 0.29% |
ALERCE INVESTMENT MANAGEMENT, L.P. | 11/13/2024 | 205,880 | $5.92 M | -3.34% | 0.25% |
KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2024 | 200,000 | $5.75 M | 0.00% | 0.25% |
SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 195,225 | $5.62 M | -43.82% | 0.24% |
KNOTT DAVID M JR | 11/13/2024 | 180,000 | $5.18 M | -11.33% | 0.22% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 176,000 | $5.06 M | 44.74% | 0.22% |
1492 CAPITAL MANAGEMENT LLC | 11/13/2024 | 161,055 | $4.63 M | -1.58% | 0.20% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 160,006 | $4.60 M | -69.68% | 0.20% |
Verona Pharma plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of VRNA shares?
During the previous two years, 167 institutional investors and hedge funds held shares of Verona Pharma plc. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 6.32 M
NEA Management Company, LLC: 5.58 M
RA CAPITAL MANAGEMENT, L.P.: 5.01 M
MAVERICK CAPITAL LTD: 4.22 M
Vivo Capital, LLC: 3.55 M
Frazier Life Sciences Management, L.P.: 3.38 M
-
What percentage of Verona Pharma plc stock is owned by institutional investors?
82.75% of Verona Pharma plc stock is owned by institutional investors.
-
How much institutional buying is happening at VRNA ?
Institutional investors have bought a total of 70.17 M shares in the last 24 months. This purchase volume represents approximately $2.72 B in transactions.